Related content

Risk Factor Analysis for the Immunogenicity of Adalimumab Associated with Decreased Clinical Response in Chinese Patients with Psoriasis

By Chiu Hsien-Yi   Wang Ting-Shun   Chan Chih-Chieh   Lin Sung-Jan   Tsai Tsen-Fang  

Acta Dermato-Venereologica, Vol. 95, Iss. 6, 2015-06 ,pp. : 711-716

Medical Journals Limited

Access to resources Recommend Favorite

Effect of Calcipotriol on Etanercept Partial Responder Psoriasis Vulgaris and Psoriatic Arthritis Patients

By Campione Elena   Mazzotta Annamaria   Paternò Evelin Jasmine   Diluvio Laura   Prinz Joerg Christoph   Chimenti Sergio  

Acta Dermato-Venereologica, Vol. 89, Iss. 3, 2009-05 ,pp. : 288-291

Medical Journals Limited

Access to resources Recommend Favorite

Topical Calcipotriol in Childhood Psoriasis

By Patrizi Annalisa   Neri Iria   Rizzoli Laura   Varotti Claudio  

Acta Dermato-Venereologica, Vol. 79, Iss. 6, 1999-10 ,pp. : 477-477

Medical Journals Limited

Access to resources Recommend Favorite

Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet®) versus calcipotriol (Daivonex®) in the treatment of psoriasis vulgaris: A randomized, multicentre, clinical trial

By Saraceno Rosita   Andreassi Lucio   Ayala Fablo   Bongiorno Maria Rita   Giannetti Alberto   Lisi Paolo   Martini Patrizia   Peris Ketty   Peserico Andrea   Chimenti Sergio  

Journal of Dermatological Treatment, Vol. 18, Iss. 6, 2007-01 ,pp. : 361-365

Informa Healthcare

Access to resources Recommend Favorite

A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris

By Torras H   Aliaga A   López-Estebaranz JL   Hernández I   Gardeazabal J   Quintanilla E   Mascaró JM  

Journal of Dermatological Treatment, Vol. 15, Iss. 2, 2004-04 ,pp. : 98-103

Informa Healthcare

Access to resources Recommend Favorite